Concepedia

Lill‐Brith von Arx

LV

Statistics

Publications

2

Citations

63

H-Index

2

Active since

2021

Affiliations

Adelphi Group (United Kingdom)(Current)

Eli Lilly (United Kingdom)

Lill‐Brith von Arx is an author at Adelphi Group (United Kingdom) specializing in medicine, clinical pharmacology, and disease burden comparison.

ORCID

Publications per year

2021–2022

2

Publications

2

Burden of Moderate to Severe Atopic Dermatitis in Adults from France, Italy, and the UK: Patient-Reported Outcomes and Treatment Patterns

C. Elise Kleyn, S. Barbarot, Catherine Reed et al. · Dermatology and Therapy · 2022 · 44 citations · Full text

, , +16

Cardiovascular risk profiles: A cross‐sectional study evaluating the generalizability of the glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials <scp>REWIND</scp> , <scp>LEADER</scp> and <scp>SUSTAIN</scp> ‐6 to the real‐world type 2 diabetes population in the <scp>United Kingdom</scp>

Joanne Webb, Julie Mount, Lill‐Brith von Arx et al. · Diabetes Obesity and Metabolism · 2021 · 19 citations · Full text

, , +17

1–2 of 2